A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation
Open Access
- 31 August 2005
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 11 (8) , 627-636
- https://doi.org/10.1016/j.bbmt.2005.05.002
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Rituximab and CHOP Induction Therapy for Newly Diagnosed Mantle-Cell Lymphoma: Molecular Complete Responses Are Not Predictive of Progression-Free SurvivalJournal of Clinical Oncology, 2002
- Rituximab: enhancing stem cell transplantation in mantle cell lymphomaBone Marrow Transplantation, 2002
- Second allogeneic transplantation after failure of first autologous transplantation.Transplantation and Cellular Therapy, 2000
- Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP ChemotherapyJournal of Clinical Oncology, 1999
- High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.Journal of Clinical Oncology, 1998
- Allogeneic bone marrow transplantation in patients who relapse after autologous transplantationBone Marrow Transplantation, 1997
- Bone marrow transplantation after failure of autologous transplant for non-Hodgkin’s lymphomaBone Marrow Transplantation, 1997
- Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphomaBlood, 1994
- Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20Blood, 1994
- Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-upBlood, 1992